Physician profile
Eiko Klimant
NPI 1154354967
$256.19
in general payments reported to CMS, 2019-2025
10 companies · $88.79 in 2025
The $88.79 reported for 2025 was less than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21.60 · 2021: $13.80 · 2022: $37.81 · 2023: $74.00 · 2024: $20.19 · 2025: $88.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $183.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $182.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $55.65 | 2023 | |
| Exelixis INC. | $32.32 | 2025 | Cabometyx |
| Pfizer INC. | $31.19 | 2025 | |
| Abbvie INC. | $25.28 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.54 | 2022 | |
| Clovis Oncology, INC. | $21.60 | 2019 | |
| Tempus Ai, INC | $20.19 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $18.35 | 2023 | Enhertu |
| Kite Pharma, INC. | $14.27 | 2022 | |
| Servier Pharmaceuticals LLC | $13.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eiko Klimant listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.